Simplex Trading
IRD

Simplex Trading’s Opus Genetics IRD Stock Holding History

Simplex Trading’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Buy
23,300
+17,800
+324% +$61.6K ﹤0.01% 5014
2025
Q4 		$11.1K Buy
+5,500
New +$11.2K ﹤0.01% 6922
2024
Q2 		– Sell
-9,400
Closed -$18K – 10031
2024
Q1 		$18K Sell
9,400
-5,500
-37% -$13.9K ﹤0.01% 7192
2023
Q4 		$44K Sell
14,900
-10,100
-40% -$29.9K ﹤0.01% 6214
2023
Q3 		$83K Sell
25,000
-3,800
-13% -$15.3K ﹤0.01% 5285
2023
Q2 		$124K Buy
28,800
+22,800
+380% +$108K ﹤0.01% 4830
2023
Q1 		$22K Buy
6,000
+3,400
+131% +$12.2K ﹤0.01% 6839
2022
Q4 		$9K Sell
2,600
-47,600
-95% -$125K ﹤0.01% 7674
2022
Q3 		$100K Buy
50,200
+5,800
+13% +$12.5K ﹤0.01% 5540
2022
Q2 		$85K Buy
44,400
+43,000
+3,071% +$97.7K ﹤0.01% 5789
2022
Q1 		$4K Sell
1,400
-114,700
-99% -$393K ﹤0.01% 9610
2021
Q4 		$433K Buy
116,100
+105,300
+975% +$422K ﹤0.01% 4015
2021
Q3 		$57K Buy
+10,800
New +$49.8K ﹤0.01% 7370

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Simplex Trading's IRD Position: Q1 2026 in Review

Simplex Trading increased its Opus Genetics (IRD) stake by 810% in Q1 2026, buying an estimated $254K and bringing the position to 82,480 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Simplex Trading first reported a position in IRD in Q1 2022 and has held it in 11 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Simplex Trading held 82,480 shares of Opus Genetics worth $375K as of Q1 2026.
  • Simplex Trading bought 73,417 Opus Genetics shares in Q1 2026, an estimated $254K.
  • Opus Genetics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3590 holding.
  • Simplex Trading first reported a position in Opus Genetics in Q1 2022 and has held it in 11 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.